06/07/2026
𝑬𝒙𝒑𝒆𝒓𝒕 𝑺𝒚𝒎𝒑𝒐𝒔𝒊𝒖𝒎 𝒐𝒏 𝑻𝒓𝒂𝒏𝒔𝒄𝒓𝒂𝒏𝒊𝒂𝒍 𝑷𝒖𝒍𝒔𝒆 𝑺𝒕𝒊𝒎𝒖𝒍𝒂𝒕𝒊𝒐𝒏 (𝑻𝑷𝑺): 𝑭𝒓𝒐𝒎 𝑳𝒊𝒗𝒊𝒏𝒈 𝒘𝒊𝒕𝒉 𝑷𝒂𝒓𝒌𝒊𝒏𝒔𝒐𝒏'𝒔 𝒕𝒐 𝑷𝒐𝒔𝒊𝒕𝒊𝒗𝒆 𝑨𝒈𝒊𝒏𝒈 🧠✨
AMSCL is honored to have co-organised the recent Expert Symposium on Transcranial Pulse Stimulation (TPS) with UHBN, held on 25 June 2026 (Thursday) at the Education University of Hong Kong (EdUHK), Tai Po Campus.
We extend our heartfelt gratitude to our four distinguished speakers, Prof. Huan-Jui YEH (Taipei Hospital), Prof. Ulrich SPRICK (Alexius/Josef Hospital, Germany), Prof. Chi-yui KWOK (The Chinese University of Hong Kong), and Dr. Pak-wing CHENG (The University of Hong Kong), for generously sharing their clinical insights and research experience with all participants.
Neurolith TPS system (Storz Medical AG, Switzerland) is a CE-marked, non-invasive brain stimulation technique that uses mechanotransduction to promote neuroplasticity and support brain health. It has shown encouraging results in conditions such as Alzheimer's disease, Parkinson's disease, depression, and other psychiatric disorders, offering a drug-free avenue for early intervention.
The symposium drew an enthusiastic turnout, with participants expressing keen interest in the science behind TPS and its clinical applications. The lab tour and hands-on session were particularly well received, giving attendees valuable direct exposure to the TPS system and sparking meaningful discussion on its potential across research. This strong response reaffirms the growing appetite for innovative, non-invasive neurotechnology.
Looking ahead, we have high hopes for EdUHK to establish itself as a leading TPS hub in the Asia Pacific, fostering ongoing workshops, symposiums, and collaborative research opportunities. We remain fully committed to supporting our researchers with continued training as this vision progresses, and to advancing brain health innovation together.
Sincere thanks to all speakers, partners, and participants who made this symposium possible.
經顱脈衝刺激（𝐓𝐏𝐒）專家研討會：從與柏金遜症共存到積極樂齡 🧠✨
志聯藥業深感榮幸，能夠支持並參與近日於香港教育大學（EdUHK）太和校園舉行的「經顱脈衝刺激（TPS）專家研討會」。活動已於2026年6月25日（星期四）圓滿落幕。
衷心感謝四位傑出講者的寶貴參與，包括葉煥居教授（台北醫院）、Prof. Ulrich SPRICK（德國Alexius/Josef醫院）、郭志銳教授（香港中文大學）及鄭博鴻醫生（香港大學）。他們不吝分享臨床經驗與研究成果，讓與會者獲益匪淺。
經顱脈衝刺激（TPS）是一項非侵入性腦部刺激技術，透過機械傳導機制促進神經可塑性，有助於維持及改善腦部健康。此技術在治療阿茲海默症、柏金遜症、抑鬱症及其他精神疾病方面，已展現出令人振奮的潛力，為日益重視主動健康管理的社會大眾，提供了一個無需依賴藥物、具前瞻性的早期介入選項。
是次研討會反應熱烈，參加者對TPS背後的科學原理及其臨床應用表現出濃厚興趣。其中，實驗室參觀與實機操作環節尤受好評，讓與會者得以親身體驗由瑞士Storz Medical AG製造的Neurolith TPS系統，並深入探討其在研究與臨床上的應用潛力。這股熱烈迴響反映了亞太地區對創新非侵入性神經科技日益增長的需求。
展望未來，志聯藥業對香港教育大學發展成為亞太區TPS重要基地充滿信心，並期待透過持續舉辦工作坊、研討會及推動相關研究合作，進一步深化此領域的發展。我們將一如既往，全力支持研究團隊在邁向此願景的過程中，獲得所需的持續培訓與資源，並期盼與各界攜手，共同推動腦部健康科技的進步。
最後，再次衷心感謝所有講者、合作夥伴、學界及參加者的鼎力支持，讓本次研討會得以順利圓滿舉行。
#志聯藥業
![[感謝聯合醫院率先引進Scrambler療法，為慢性疼痛患者帶來曙光]很榮幸我們代理的 Scrambler 療法，獲得聯合醫院的肯定與引進。這項在國際疼痛領域備受關注的非藥物止痛技術，能為特定慢性疼痛患者提供新的龧光。 #聯合醫院 #...](https://img4.findhealthclinics.org/520/329/1569335815203299.jpg)
